Oncoclínicas do Brasil Serviços Médicos S.A. (BVMF:ONCO3)
Brazil flag Brazil · Delayed Price · Currency is BRL
1.520
-0.030 (-1.94%)
May 7, 2026, 10:55 AM GMT-3

BVMF:ONCO3 Income Statement

Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5,7396,2275,4894,0882,702
Revenue Growth (YoY)
-7.83%13.45%34.26%51.30%32.77%
Cost of Revenue
3,9534,1673,5602,6361,833
Gross Profit
1,7862,0601,9291,452868.79
Selling, General & Admin
1,3611,3971,172980.82688.05
Other Operating Expenses
1,790-20.37-13.160.193.53
Operating Expenses
3,1521,3761,159981.01691.58
Operating Income
-1,365684.02769.67471.1177.22
Interest Expense
-648.12-728.16-563.39-490.11-154.36
Interest & Investment Income
158.49143.44105.54141.0854.41
Earnings From Equity Investments
0.18-7.9-11.65-0.54-
Currency Exchange Gain (Loss)
14.68-297.92--
Other Non Operating Income (Expenses)
-609.9991.588.87--10.98
EBT Excluding Unusual Items
-2,450153.98316.95121.5466.29
Gain (Loss) on Sale of Investments
-67.11----
Asset Writedown
-625.33-796.07---
Legal Settlements
-20.16-14.77-14.43--3.95
Pretax Income
-3,163-656.86302.52121.5462.34
Income Tax Expense
508.4760.57-10.047.7784.75
Earnings From Continuing Operations
-3,671-717.43312.56113.77-22.42
Minority Interest in Earnings
47.3271.24-88.94-67.51-24.48
Net Income
-3,624-646.19223.6246.26-46.9
Net Income to Common
-3,624-646.19223.6246.26-46.9
Net Income Growth
--383.39%--
Shares Outstanding (Basic)
867616524480412
Shares Outstanding (Diluted)
867616536532412
Shares Change (YoY)
40.59%15.09%0.72%28.93%2.65%
EPS (Basic)
-4.18-1.050.430.10-0.11
EPS (Diluted)
-4.18-1.050.420.09-0.11
EPS Growth
--379.95%--
Free Cash Flow
-286.75-399.1-363.26-571.82-211.23
Free Cash Flow Per Share
-0.33-0.65-0.68-1.07-0.51
Gross Margin
31.12%33.09%35.14%35.52%32.15%
Operating Margin
-23.79%10.98%14.02%11.52%6.56%
Profit Margin
-63.14%-10.38%4.07%1.13%-1.74%
Free Cash Flow Margin
-5.00%-6.41%-6.62%-13.99%-7.82%
EBITDA
-1,192874.68931.27646.25270.2
EBITDA Margin
-20.77%14.05%16.97%15.81%10.00%
D&A For EBITDA
173.37190.65161.6175.1592.99
EBIT
-1,365684.02769.67471.1177.22
EBIT Margin
-23.79%10.98%14.02%11.52%6.56%
Effective Tax Rate
---6.39%135.96%
Revenue as Reported
5,7396,2275,4894,0882,702
Source: S&P Global Market Intelligence. Standard template. Financial Sources.